If you're seeing this message, that means
JavaScript has been disabled on your browser
, please
enable JS
to make this app work.
No tags found
Companies
No companies found
Advanced Search
Newsfeed
Alerts
Saved Lists
Sign Up for Free
Login
Get Updates
196
Followers on Owler
Kalbe Farma researches and develops a range of medicines and healthcare products for humans and animals...
Read more
Overview
Competitors
Acquisitions
News & Insights
Kalbe Farma researches and develops a range of medicines and healthcare products for humans and animals...
Read more
President & CEO
- Vidjongtius
CEO Approval Rating
87/100
Weigh In
1966
Jakarta
Jakarta Raya
Public
IDX
KLBF
Pharmaceuticals & Biotechnology
Pharmaceuticals
2834
NAICS listing
https://www.kalbe.co.id
Annual Revenue
$1.5B
Employees
17,000
Acquisitions
1
News
Latest News
Apr 02, 2025
IDN Financials
PT Kalbe Farma Tbk: KLBF potentially distribute 45% to 55% dividend for 2024
Mar 28, 2025
IDN Financials
PT Kalbe Farma Tbk: KLBF recorded IDR3.24 trillion in profit, up 17.13%
Feb 19, 2025
IDN Financials
PT Kalbe Farma Tbk: Kalbe Farma withdraws 61.7 million treasury shares
Oct 30, 2024
Marketscreener
PT Kalbe Farma Tbk: PT Kalbe Farma Tbk. Reports Earnings Results for the Nine Months Ended September 30, 2024
Oct 16, 2024
IDN Financials
PT Kalbe Farma Tbk: KLBF strengthens prescription drug business by inaugurating radioisotope factory
May 29, 2024
MarketScreener
PT Kalbe Farma Tbk: PT Kalbe Farma Tbk : Kalbe to Buy Back Shares of Rp1 trillion
May 02, 2024
MarketScreener
PT Kalbe Farma Tbk: PT Kalbe Farma Tbk : Company Update - Q1 2024 Unaudited Results (02-May-2024)
Apr 05, 2024
IDN Financials
PT Kalbe Farma Tbk: Allocating IDR 1 trillion, KLBF to set buyback of 625 million shares | IDNFinancials
Apr 02, 2024
Marketscreener
PT Kalbe Farma Tbk: PT Kalbe Farma Tbk. Reports Earnings Results for the Full Year Ended December 31, 2023
Nov 22, 2023
IDN Financials
PT Kalbe Farma Tbk: Q3 ended, KLBF saw 16.9% decline | IDNFinancials
Follow and Get Alerts
PT Kalbe Farma Tbk Competitors
1
Follow
2
Follow
3
Follow
Unlock more competitors
Trending Companies